top of page
32200c5c-7c4c-438f-a9df-3119a2398bf2.png
Autchmaber1.png
ai-cvd.png
AI-CVD Summary
Coronary Calcification
816_aicvd (8)_4_edited.jpg
‌ Aortic Calcification
ٍEpicardial Fat _edited.jpg
Epicardial Fat
816_aicvd (8)_5_edited.jpg
Cardiac Chambers
816_aicvd (8)_7_edited.jpg
Aorta & PA Size
816_aicvd (8)_10_edited.jpg
Lung LAI
816_aicvd (8)_9_edited.jpg
Lung HAI
816_aicvd (8)_11_edited.jpg
Liver Fat
816_aicvd (8)_12_edited.jpg
Muscle & Visceral Fat
816_aicvd (8)_13_edited.jpg
Bone Density
f055739f-1956-41a1-8156-cda95d1fea9f.png
AI-CVD Bundle
Muscle and Fat Analysis.png
Liver Attenuation.png
Cardiac Chambers Volumetry.png
ٍEpicardial Fat .png
Bone Mineral Density (BMD) .png
coronaryArteryCalcification.png
Lung Density Report- High Attenuation Index.png
Thoracic Aorta and Pulmonary Artery Sizing .png
Aortic Wall Aortic and Mitral Valve Report.png
Lung Density Report- Low Attenuation Index.png
AI-CVD--.png
Frame 1000008286.png
Frame 1000008286.png
Frame 1000008287.png

AI-CAC improves on CAC for Cardiovascular Risk prediction: The Multi-Ethnic Study of Atherosclerosis

Nov 27, 2024
2 min read


AUTHORS (FIRST NAME, LAST NAME):

Morteza Naghavi, Anthony Reeves, Matthew Budoff, Dong Li, Kyle Atlas, Chenyu Zhang, Thomas Atlas, Sion K. Roy, Nathan D. Wong, Claudia Henschke, and David Yankelevitz.


Abstract:


Background:

Traditionally derived coronary artery calcium (CAC) scoring offers valuable information beyond traditional risk factors that significantly improve early detection of patients at risk for cardiovascular events.  We examined whether artificial intelligence-enabled methods utilizing the CAC scan may provide further improvement in overall cardiovascular disease (CVD) risk prediction.


Methods:

We applied artificial intelligence-enabled automated cardiac chambers volumetry to CAC scans (AI-CAC) of 5830 asymptomatic individuals (52.2% women, age 61.7±10.2 years) that were previously obtained for CAC scoring in the baseline examination (2000-2002) of the Multi-Ethnic Study of Atherosclerosis (MESA). The primary outcome was a composite of all cardiovascular events comprised of stroke, myocardial infarction, angina, resuscitated cardiac arrest, all cardiovascular disease related deaths, heart failure, and atrial fibrillation. We used the 15-year outcomes data and assessed discrimination using the time-dependent area under the curve (AUC) and Uno’s C-statistic between AI-CAC with Agatston CAC Score.


Results:

Over 15-years follow-up, 1773 cardiovascular events accrued. AI-CAC automated cardiac chambers volumetry took on average 21 seconds per CAC scan. The C-statistic for cardiovascular events between AI-CAC and Agatston CAC Score was 0.746 (CI: 0.724-0.768) versus 0.707 (CI: 0.683-0.723) for females, respectively (p<.0001) and 0.680 (CI: 0.653-0.707) versus 0.657 (CI: 0.632-0.682) for males, respectively (P=0.0012).  The category-free Net Reclassification Index of AI-CAC over CAC at 15-years follow-up for cardiovascular events was 0.29 (p<.0001).

 

Conclusion:

In this multi-ethnic longitudinal population study followed for 15 years, the addition of AI-CAC measurements significantly improved on Agatston CAC score for all cardiovascular event prediction.






Comments


Ready to Unlock the Value in Your CT Scans?

Join leading healthcare providers using AI-CVD to save lives and increase revenue, and lead the future of preventive cardiology.

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Youtube

2450 Holcombe Blvd
TMC Innovations
Houston, TX 77021

aicvd patent_edited_edited.jpg
ISO LOGO_edited.png
autoliver patent.png

©2026 HeartLung Corporation. All Rights Reserved. US Patent Nos US9119590*, US10695022, US11610686, US18167691, US20240115224, and Patents Pending. AI-CVD, AI-CAC, AutoBMD, AutoCAC, AutoChamber and other trademarks shown on this website are protected under intellectual property rights of HeartLung Corporation in the United States.

bottom of page